Stock Markets June 25, 2026 04:46 AM

Citi Lifts L'Oréal to Buy, Sees Stronger Growth Path as Kering Beauty Is Integrated

Broker raises target to €435 and forecasts faster organic expansion from 2027 as Kering Beauty assets bolster fragrance and luxury portfolio

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn

Citi upgraded L'Oréal SA (EPA: OREP) to a 'buy' rating from 'neutral' and raised its price target to €435 from €375. The bank expects the cosmetics group to enter a higher long-term growth phase as the Kering Beauty acquisition is integrated, and projects sustainable organic sales growth of 5.5%-6.5% from 2027. Citi also raised EPS forecasts for 2027-2029 and argued several short-term concerns should diminish over time.

Citi Lifts L'Oréal to Buy, Sees Stronger Growth Path as Kering Beauty Is Integrated
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Citi upgraded L'Oréal to 'buy' and raised its price target to €435 from €375, projecting a stronger growth phase driven by Kering Beauty integration.
  • Broker now forecasts sustainable organic sales growth of 5.5%-6.5% from 2027, up from a prior 4.5%-5.5% outlook, and expects Kering Beauty to add up to 100 basis points to growth between 2027 and 2030.
  • EPS estimates for 2027-2029 were increased by roughly 2.4% annually; Citi argued short-term concerns such as Galderma uncertainty and SAP reporting changes should fade, potentially supporting a valuation re-rating.

Overview

Citi has moved L'Oréal SA (EPA: OREP) up to a 'buy' recommendation from 'neutral' and increased its price target to €435, up from €375. The brokerage said the expected integration of Kering Beauty - which includes the Creed fragrance business and the future Gucci Beauty license - and improving organic sales momentum position the group for a stronger, sustained growth phase beginning in the latter part of the decade.

Growth expectations and timeline

In its revised outlook, Citi now expects L'Oréal's organic sales growth to accelerate into a sustainable range of 5.5% to 6.5% beginning in 2027. That replaces the bank's earlier guidance of 4.5% to 5.5%. Citi said the Kering Beauty transaction should act as a meaningful growth engine over coming years as Creed is expanded and new fragrance launches and the Gucci Beauty business are rolled out.

Quantifying the Kering Beauty impact

The brokerage estimated the integration of Kering Beauty could contribute as much as 100 basis points to L'Oréal's organic sales growth in the 2027-2030 window. Citi flagged specific levers for that contribution - expansion of the Creed franchise, future fragrance releases and the prospects tied to the Gucci Beauty license.

Earnings and valuation implications

Reflecting the stronger revenue outlook, Citi raised its earnings-per-share estimates for 2027 through 2029 by roughly 2.4% per year. The bank said the upgraded earnings trajectory and the prospects from Kering Beauty could support a re-rating of L'Oréal's valuation versus peers.

Near-term headwinds and investor focus

Citi acknowledged expectations for a slower showing in the second half of 2026 but argued the weakness will largely reflect tougher year-earlier comparisons rather than a deterioration in fundamental demand. The brokerage suggested investor attention should shift toward L'Oréal's improved growth profile as the company progresses into 2027.

Other factors cited

The bank also noted several issues that have weighed on L'Oréal shares - uncertainty around Galderma, SAP-related reporting changes and concerns over slowing growth - and said these are likely to fade over time, which could enable L'Oréal to outperform consumer staples peers.

Market reaction

Shares of L'Oréal rose 1.6% to €393.00 on Thursday, reaching their highest level since June 15.


Reporting focus: analysis of growth drivers, integration impacts and investor implications based on the Citi upgrade.

Risks

  • An expected slowdown in H2 2026 could weigh on near-term sentiment - impacts the consumer discretionary and consumer staples sectors due to visibility concerns around sales momentum.
  • Uncertainty surrounding Galderma remains a material issue cited by Citi - has implications for L'Oréal's operations and investor perception in the cosmetics sector.
  • SAP-related reporting changes and worries over slowing growth could continue to affect comparability and market confidence until those issues are resolved - relevant to corporate reporting and investor relations across consumer staples.

More from Stock Markets

Deutsche Bank Elevates Vonovia to Buy, Lifts Target to €26 as It Reprices Residential Names Jun 25, 2026 McCormick Tops Estimates, Reaffirms Fiscal 2026 Targets as Margins Improve Jun 25, 2026 Eni Shares Slip as Oil Prices Pull Energy Sector Lower Jun 25, 2026 McCormick Tops Estimates as Home Cooking Fuels Spice and Seasoning Demand Jun 25, 2026 Darden Shares Pull Back Ahead of Fiscal Q4 Results as Olive Garden Worries Weigh Jun 25, 2026